Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [557]
Citations
Cites
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationProstaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Self-citationA SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationTHE PROSTAGLANDINS: A FAMILY OF BIOLOGICALLY ACTIVE LIPIDS
BERGSTRÖM, S., CARLSON, L. A., & WEEKS, J. R. (1968) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07108-x · Cited by 634
Prostaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Cutaneous reactions to intradermal prostaglandins
Crunkhorn, P., & Willis, A. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb09934.x · Cited by 348
The enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Beerthuis, R. K., & van Dorp, D. A. (1966) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19660850412 · Cited by 339
Research works printed but not linked: 11
- Jacques, R., Helv. Physiol. Pharmacol. Acta, 23, 156 (1965).
- Berry, P. A., thesis, Council for National Academic Awards, London, 91 (1966).
- Vargaftig, B. B., and Dao, N., Pharmacology (in the press).
- Piper, P. J., and Vane, J. R., in Prostaglandins (edit. by Ramwell, P., and Shaw, J.) (NY Acad. Sci., in the press, 1971).
- Willis, A. L., Brit. J. Pharmacol., 40, 583P (1970).
- Milton, A. S., and Wendlandt, S. J., J. Physiol., 207, 76P (1970).
- Feldberg, W., and Saxena, P. N., J. Physiol. (in the press, 1971).
- Willis, A. L., in Prostaglandins, Peptides and Amines (edit. by Mantegazza, P., and Horton, E. W.), 31 (Academic Press, London, 1969).
- Collier, H. O. J., Nature (in the press).
- Goodman, L. S., and Gilman, A., The Pharmacological Basis ofTherapeutics, fourth ed. (Collier-Macmillan, London, 1970).
- Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R., J. Pharmac. Exp. Therap., 153, 237 (1966).
Cited by
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Ecotoxicology of human pharmaceuticals
Fent, K., Weston, A. A., & Caminada, D. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2005.09.009 · Cited by 3,223
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Self-citationThe biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
Hunskaar, S., & Hole, K. (1987) · Pain · doi:10.1016/0304-3959(87)90088-1 · Cited by 2,186
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Self-citationACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationFlavonoids, a class of natural products of high pharmacological potency
Havsteen, B. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90262-9 · Cited by 1,615
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Self-citationMalfertheiner, P., Chan, F. K., & McColl, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,488
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
Hamberg, M., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3400 · Cited by 1,407
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
The mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Self-citationArachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
Moncada, S., & Vane, J. R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905173002006 · Cited by 1,221
Self-citationGreenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
“synthase (PGHS), now more often referred to as cyclooxygenase (COX), was elucidated as the target for the inhibition by aspirin and other NSAIDs [9].”
BackgroundHerschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Phospholipid Methylation and Biological Signal Transmission
Hirata, F., & Axelrod, J. (1980) · Science · doi:10.1126/science.6157192 · Cited by 1,095
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Cytoprotection by prostaglandins
Robert, A. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90235-x · Cited by 1,063
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.
Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,033
Self-citationAcetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects
Cleuvers, M. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00068-7 · Cited by 990
Intracellular phospholipases A
Van Den Bosch, H. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90574-x · Cited by 982
Aspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationFLOWER, R. J., & BLACKWELL, G. J. (1979) · Nature · doi:10.1038/278456a0 · Cited by 917
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
Blackwell, G. J., Carnuccio, R., Rosa, M. D., Flower, R. J., Parente, L., & Persico, P. (1980) · Nature · doi:10.1038/287147a0 · Cited by 915
gem-Disubstituent Effect: Theoretical Basis and Synthetic Applications
Jung, M. E., & Piizzi, G. (2005) · Chemical Reviews · doi:10.1021/cr940337h · Cited by 903
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Lüscher, T. F., & Vanhoutte, P. M. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.344 · Cited by 878
Toxic effects of the non-steroidal anti-inflammatory drug diclofenac
Schwaiger, J., Ferling, H., Mallow, U., Wintermayr, H., & Negele, R. D. (2004) · Aquatic Toxicology · doi:10.1016/j.aquatox.2004.03.014 · Cited by 868
Prostaglandins, Aspirin-like Drugs and Analgesia
FERREIRA, S. H. (1972) · Nature New Biology · doi:10.1038/newbio240200a0 · Cited by 866
Mur, L. A. J., Kenton, P., Atzorn, R., Miersch, O., & Wasternack, C. (2006) · Plant Physiology · doi:10.1104/pp.105.072348 · Cited by 864
Control of vascular permeability by polymorphonuclear leukocytes in inflammation
Wedmore, C. V., & Williams, T. J. (1981) · Nature · doi:10.1038/289646a0 · Cited by 849
New insights into the mode of action of anti-inflammatory drugs
Vane, J. R., & Botting, R. M. (1995) · Inflammation Research · doi:10.1007/bf01630479 · Cited by 838
Self-citationAdvances in covalent drug discovery
Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Gum, P. A., Kottke-Marchant, K., Poggio, E. D., Gurm, H., Welsh, P. A., Brooks, L., Sapp, S. K., & Topol, E. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01631-9 · Cited by 820
Cleuvers, M. (2004) · Ecotoxicology and Environmental Safety · doi:10.1016/s0147-6513(03)00141-6 · Cited by 814
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Anti-inflammatory drugs and their mechanism of action
Vane, J. R., & Botting, R. M. (1998) · Inflammation Research · doi:10.1007/s000110050284 · Cited by 798
Self-citationProstaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia
Cunha, F. Q., Poole, S., Lorenzetti, B. B., & Ferreira, S. H. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14503.x · Cited by 792
Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties
Needleman, P., Raz, A., Minkes, M. S., Ferrendelli, J. A., & Sprecher, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.2.944 · Cited by 780
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Self-citationCyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
Oates, J. A., Wood, A. J. J., Brooks, P. M., & Day, R. O. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242407 · Cited by 775
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Webb, D. R. (1980) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(80)90024-0 · Cited by 768
Gastric Mucosal Defense and Cytoprotection: Bench to Bedside
Laine, L., Takeuchi, K., & Tarnawski, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.030 · Cited by 767
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
IARC Handbooks of Cancer Prevention: Breast cancer screening
Feig, S. A. (2003) · Cancer · doi:10.1002/cncr.11334 · Cited by 742
Grace, P. A. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810504 · Cited by 720
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
Wallace, J. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00004.2008 · Cited by 716
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Malmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710
Prostaglandins, Arachidonic Acid, and Inflammation
Kuehl, F. A., & Egan, R. W. (1980) · Science · doi:10.1126/science.6254151 · Cited by 708
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 700
Vane, J. (1994) · Nature · doi:10.1038/367215a0 · Cited by 699
Self-citationBaracos, V., Rodemann, H. P., Dinarello, C. A., & Goldberg, A. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303103081002 · Cited by 690
Cyclooxygenases: structural and functional insights
Rouzer, C. A., & Marnett, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800042-jlr200 · Cited by 688
Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs
Vane, J. R., & Botting, R. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00203-9 · Cited by 688
Self-citationThe anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.
Zarghi, A., & Arfaei, S. (2011) · PubMed Central · Cited by 680
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.
Miyamoto, T., Ogino, N., Yamamoto, S., & Hayaishi, O. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33534-2 · Cited by 663
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
The importance of phospholipase-A2 in prostaglandin biosynthesis
Flower, R. J., & Blackwell, G. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90216-1 · Cited by 642
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 641
Metadata
- Authors
- VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Corresponding author
- VANE, J. R.
- Venue
- Nature New Biology
- Published
- 1971-06
- Volume
- 231
- Issue
- 25
- Pages
- 232-235
- ISSN
- 0090-0028 (ISSN-L)
- 2058-1092
- OpenAlex
- W2008574207
- Cited by
- 8,605
- References
- 26
- Citations by year
- 2026: 51 · 2025: 72 · 2024: 86 · 2023: 106 · 2022: 117 · 2021: 121 · 2020: 118 · 2019: 114 · 2018: 123 · 2017: 150 · 2016: 144 · 2015: 154 · 2014: 154 · 2013: 162 · 2012: 190
- FWCI
- 183.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature New Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- aspirin, salicylates, prostaglandin synthesis inhibition, mechanism of action, guinea pig lung, anti-inflammatory agents
- MeSH terms
- Animals, Arachidonic Acids, Aspirin, Biological Assay, Chromatography, Thin Layer, Colon, Guinea Pigs, Indomethacin, Lung, Prostaglandins, Salicylates, Stomach, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.